Muscular Dystrophy Trial, Recruiting NCT07423026 Sponsor: University of Oxford Condition: Muscular Dystrophy
Back to Muscular Dystrophy

Muscular Dystrophy Trial, Recruiting

NCT07423026
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For a child with DMD:

  • The child must be male
  • The child must be between 1 and 3 years old
  • The child must be able to walk at least 10 metres on their own
  • The child must have a confirmed diagnosis of Duchenne Muscular Dystrophy (DMD) through genetic testing
  • The parent(s) or legal guardian(s) must be willing and able to give written permission for the child to take part
  • The parent(s) or legal guardian(s) must be willing and able to take part in the study themselves

For the parent or legal guardian:

  • Must be 18 years old or over
  • Must be the legal carer of the child diagnosed with DMD
  • Must be willing to follow the study procedures and help with assessments done remotely (e.g., from home)
  • Must be willing to sign the consent form
  • Must be able to understand all information provided about the study, as assessed by the research team

For healthy comparison children (controls):

  • Must be male
  • Must be between 1 and 3 years old
  • Must be able to walk at least 10 metres on their own
  • Must have a parent or legal guardian willing to participate

Who may not be able to join:

For a child with DMD:

  • The child has had surgery or a significant injury to an arm or leg in the last 6 months
  • The child has another serious ongoing or recent illness or condition that affects their ability to move (within the last 3 weeks)
  • The child was born prematurely (before 37 weeks of pregnancy)
  • The child is already taking steroid tablets (oral corticosteroids) to treat their DMD
  • The child is already taking part in another clinical trial testing a treatment
  • The child has any other health condition that the doctor feels would prevent them from completing the study assessments

For healthy comparison children (controls):

  • The child has had surgery or a significant injury to an arm or leg in the last 6 months
  • The child has a serious ongoing condition that affects their ability to move
  • The child has had a serious short-term condition affecting their ability to move within the last 3 weeks
  • The child was born prematurely (before 37 weeks of pregnancy)
  • The child has concerns around neurodevelopment or has been delayed in reaching standard childhood developmental milestones
  • The child has any other health condition that the doctor feels would prevent them from completing the study assessments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +44 (0)1865 618799

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 June 2026
Est. completion
1 October 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

To assess the within-patient variability in SV95C using the Syde device to remotely assess motor function in boys with DMD under the age of four.; To assess the test-retest reliability of the Syde device to remotely assess motor function in boys with DMD under the age of four.; To assess compliance with the Syde device in boys with DMD under the age of four.; To assess the acceptability of using the Syde device in boys with DMD under the age of four.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov